<DOC>
	<DOC>NCT01140217</DOC>
	<brief_summary>The purpose of this study is to determine whether NEA TDS is effective in the prevention of pregnancy. The safety of this product will also be evaluated.</brief_summary>
	<brief_title>Efficacy and Safety Study of Norethindrone Acetate Transdermal Delivery System in Contraception</brief_title>
	<detailed_description>An Open Label Study to Evaluate the Contraceptive Efficacy and Safety of Norethindrone Acetate Transdermal Delivery System.</detailed_description>
	<mesh_term>Norethindrone acetate</mesh_term>
	<mesh_term>Norethindrone</mesh_term>
	<criteria>Healthy females 1845 years Regular, consistent menstrual cycles between 25 and 35 days Sexually active and at risk of becoming pregnant History of infertility Known contraindications to progestogen administration Pap smear suggestive of a highgrade precancerous lesion(s) Clinically significant deviation from normal in any of the screening tests or exams</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>contraception</keyword>
	<keyword>pregnancy</keyword>
</DOC>